Skip to main content
OpenTrials

Clinical trial condition

Arthritis

Explore clinical trials studying Arthritis. Study availability and eligibility vary by location and protocol.

7,582 public trials 912 recruiting studies
Refine in advanced search Browse all conditions

Arthritis trial results

Completed

Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment

NCT03112213

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Rheumazentrum Kupka Altenburg, Germany
  • Praxis für Rheumatologie. Amberg, Germany
  • Kerckhoff-Klinik; Rheumatologie&klin.Immunologie Bad Nauheim, Germany
  • Charité Campus Mitte, Med.Klinik, Rheumatologie und Klinische Immunologie Berlin, Germany
View all 27 locations
View Trial Details
Completed

Sinew Acupuncture for Knee Osteoarthritis

NCT03099317

Conditions
Arthritis, Joint Diseases, Knee Osteoarthritis, +8 more
Locations
  • The Hong Kong Tuberculosis, Association The University of Hong Kong Clinical Centre for Teaching and Research in Chinese Medicine (Wan Chai) Wan Chai, Hong Kong
View Trial Details
Completed

A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)

NCT02614716

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
  • New Mexico Clinical Research & Osteoporosis Center Albuquerque, New Mexico, United States
  • NorthEast Rheumatology Concord, North Carolina, United States
  • Altoona Center for Clinical Research Duncansville, Pennsylvania, United States
View Trial Details
Completed

A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)

NCT00650624

Conditions
Arthritis, Joint Diseases, Musculoskeletal Diseases, +3 more
Locations
  • Pfizer Investigational Site Funabashi, Chiba, Japan
  • Pfizer Investigational Site Sakura, Chiba, Japan
  • Pfizer Investigational Site Chikushi-gun, Fukuoka, Japan
  • Pfizer Investigational Site Iizuka, Fukuoka, Japan
View all 22 locations
View Trial Details
Completed

A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

NCT02046603

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Christchurch Hospital; Rheumatology Bournemouth, United Kingdom
  • Royal Sussex County Hospital; Clinical Investigation Research Unit Brighton, United Kingdom
  • Queens Hospital Burton-on-Trent, United Kingdom
View all 38 locations
View Trial Details
Completed

A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy

NCT00689728

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mesa, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palm Desert, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Riverside, California, United States
View all 45 locations
View Trial Details
Completed

A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan

NCT00648258

Conditions
Arthritis, Joint Diseases, Musculoskeletal Diseases, +4 more
Locations
  • Pfizer Investigational Site Kweishan, Taoyuan, Taiwan
  • Pfizer Investigational Site Kaohsiung City, Taiwan
  • Pfizer Investigational Site Taichung, Taiwan
  • Pfizer Investigational Site Taipei, Taiwan
View Trial Details

Related conditions